Immunome, Inc.
IMNM
$7.91
$0.7410.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.51% | -13.73% | -10.12% | 124.19% | 52.41% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.22% | -34.08% | 63.84% | -44.83% | 1,063.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.30% | -14.16% | -9.27% | 116.53% | 58.29% |
|
|
|||||
| Total Current Assets | -9.30% | -14.16% | -9.27% | 116.53% | 58.29% |
| Net Property, Plant & Equipment | 50.53% | 10.92% | 49.64% | 58.37% | 139.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.78% | -0.42% | 395.81% | 234.00% | -13.04% |
| Total Assets | -6.48% | -13.27% | -7.36% | 115.26% | 59.44% |
|
|
|||||
| Total Accounts Payable | 303.33% | -50.08% | -1.84% | 116.82% | 18.84% |
| Total Accrued Expenses | 23.51% | 30.72% | 85.03% | 48.50% | 170.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -75.49% | -12.88% | -29.59% | 35.16% | 35.96% |
| Total Finance Division Other Current Liabilities | -14.94% | -20.19% | 4.45% | 14.03% | -35.91% |
| Total Other Current Liabilities | -14.94% | -20.19% | 4.45% | 14.03% | -35.91% |
| Total Current Liabilities | 37.39% | -0.93% | 29.68% | 40.95% | -5.55% |
|
|
|||||
| Total Current Liabilities | 37.39% | -0.93% | 29.68% | 40.95% | -5.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 93.55% | -0.52% | 105.39% | -10.00% | 998.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -59.77% | -91.40% |
| Total Liabilities | 40.68% | -0.91% | 23.97% | 19.28% | -67.09% |
|
|
|||||
| Common Stock & APIC | 7.15% | 1.26% | 0.69% | 86.15% | 151.50% |
| Retained Earnings | -18.43% | -12.13% | -10.25% | -58.12% | -71.16% |
| Treasury Stock & Other | -18.57% | 3,400.00% | -50.00% | -81.82% | -- |
| Total Common Equity | -15.70% | -15.34% | -11.11% | 138.21% | 1,873.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.70% | -15.34% | -11.11% | 138.21% | 1,873.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.70% | -15.34% | -11.11% | 138.21% | 1,873.04% |
|
|
|||||